+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Kifunensine Market 2021-2027

  • PDF Icon

    Report

  • 100 Pages
  • February 2022
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5559356
Global Kifunensine Market Size, Share & Trends Analysis Report, By Type (Low Purity (Below 97%), Purity (Above 97% and Below 99%), High Purity (Above 99%), and Others), By Application (Cancer Treatment, Neurological Treatment, Endocrinological Treatment, and Others), and Forecast (2021-2027)

The global kifunensine market is anticipated to grow at a considerable CAGR during the forecast period. The European Commission approved the kifunensine orphan designation for the treatment of beta sarcoglycanopathy. The therapeutic potential of kifunensine is now being investigated in several diseases that benefit from its ability to inhibit mannosidase I. the growing incidence of cancer and neurological disorders has driven the growth of the global kifunensine market.

The global kifunensine market is segmented based on type and application. Based on type, the kifunensine market is segmented into high purity (above 99%), low purity (below 97%), purity (above 97% and below 99%) and other kifunensine. Based on application, the kifunensine market is segmented into cancer treatment, neurological treatment, endocrinological treatment, and others.

Geographically, the global kifunensine market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global kifunensine market include R&D Systems, Inc., Anward, Cayman Chemical Co., Abcam Plc, Alfa Chemistry, Stemgent, Inc., and STEMCELL Technologies Inc. among others.

Market Segmentation


  • Global Kifunensine Market Research and Analysis by Type
  • Global Kifunensine Market Research and Analysis by Application

The Report Covers


  • Comprehensive research methodology of the global kifunensine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global kifunensine market.
  • Insights about market determinants that are stimulating the global kifunensine market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Kifunensine Market by Type
4.1.1. High Purity (Above 99%)
4.1.2. Low Purity (Below 97%)
4.1.3. Purity (Below 99% and Above 97%)
4.1.4. Others
4.2. Global Kifunensine Market by Application
4.2.1. Cancer Treatment
4.2.2. Neurological Treatment
4.2.3. Endocrinological Treatment
4.2.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. R&D Systems, Inc.
6.2. Anward
6.3. Cayman Chemical Co.
6.4. Abcam Plc
6.5. Alfa Chemistry
6.6. Stemgent, Inc.
6.7. Glentham Life Sciences
6.8. STEMCELL Technologies Inc.
6.9. Santa Cruz Biotechnology, Inc.
6.10. Race Chemical Shanghai Race Chemical Co., Ltd.
6.11. Aurum Pharmatech LLC
List of Tables
1. Global Kifunensine Market Research and Analysis by Type, 2020-2027 ($ Million)
2. Global High Purity (Above 99%) Kifunensine Market Research and Analysis by Region, 2020-2027 ($ Million)
3. Global Low Purity (Below 97%) Kifunensine Market Research and Analysis by Region, 2020-2027 ($ Million)
4. Global Purity (Below 99% and Above 97%) Kifunensine Market Research and Analysis by Region, 2020-2027 ($ Million)
5. Global Other Purity Level Kifunensine Market Research and Analysis by Region, 2020-2027 ($ Million)
6. Global Kifunensine Market Research and Analysis by Application, 2020-2027 ($ Million)
7. Global Kifunensine for Cancer Treatment Market Research and Analysis by Region, 2020-2027 ($ Million)
8. Global Kifunensine for Neurological Treatment Market Research and Analysis by Region, 2020-2027 ($ Million)
9. Global Kifunensine for Endocrinological Treatment Market Research and Analysis by Region, 2020-2027 ($ Million)
10. Global Kifunensine for Other Application Market Research and Analysis by Region, 2020-2027 ($ Million)
11. Global Kifunensine Market Research and Analysis by Geography, 2020-2027 ($ Million)
12. North American Kifunensine Market Research and Analysis by Country, 2020-2027 ($ Million)
13. North American Kifunensine Market Research and Analysis by Type, 2020-2027 ($ Million)
14. North American Kifunensine Market Research and Analysis by Application, 2020-2027 ($ Million)
15. European Kifunensine Market Research and Analysis by Country, 2020-2027 ($ Million)
16. European Kifunensine Market Research and Analysis by Type, 2020-2027 ($ Million)
17. European Kifunensine Market Research and Analysis by Application, 2020-2027 ($ Million)
18. Asia-Pacific Kifunensine Market Research and Analysis by Country, 2020-2027 ($ Million)
19. Asia-Pacific Kifunensine Market Research and Analysis by Type, 2020-2027 ($ Million)
20. Asia-Pacific Kifunensine Market Research and Analysis by Application, 2020-2027 ($ Million)
21. Rest of the World Kifunensine Market Research and Analysis by Type, 2020-2027 ($ Million)
22. Rest of the World Kifunensine Market Research and Analysis by Application, 2020-2027 ($ Million)
List of Figures
1. Globalkifunensine Market Share by Type, 2020 Vs 2027 (%)
2. Globalkifunensine Market Share by Application, 2020 Vs 2027 (%)
3. Global Kifunensine Market Share by Geography, 2020 Vs 2027 (%)
4. Us Kifunensine Market Size, 2020-2027 ($ Million)
5. Canada Kifunensine Market Size, 2020-2027 ($ Million)
6. UK Kifunensine Market Size, 2020-2027 ($ Million)
7. France Kifunensine Market Size, 2020-2027 ($ Million)
8. Germany Kifunensine Market Size, 2020-2027 ($ Million)
9. Italy Kifunensine Market Size, 2020-2027 ($ Million)
10. Spain Kifunensine Market Size, 2020-2027 ($ Million)
11. Rest of Europe Kifunensine Market Size, 2020-2027 ($ Million)
12. India Kifunensine Market Size, 2020-2027 ($ Million)
13. China Kifunensine Market Size, 2020-2027 ($ Million)
14. Japan Kifunensine Market Size, 2020-2027 ($ Million)
15. Rest of Asia-Pacific Kifunensine Market Size, 2020-2027 ($ Million)
16. Rest of the World Kifunensine Market Size, 2020-2027 ($ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • R&D Systems, Inc.
  • Anward
  • Cayman Chemical Co.
  • Abcam Plc
  • Alfa Chemistry
  • Stemgent, Inc.
  • Glentham Life Sciences
  • STEMCELL Technologies Inc.
  • Santa Cruz Biotechnology, Inc.
  • Race Chemical Shanghai Race Chemical Co., Ltd.
  • Aurum Pharmatech LLC